Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

7(77.8%)

Phase 1

2(22.2%)

9Total

N/A(7)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06058403Not ApplicableCompleted

Impact of Canola Protein Processing on Plasma Amino Acid Responses

Role: collaborator

NCT00471263Not ApplicableCompleted

The Effects of Milk Proteins on Blood Pressure

Role: collaborator

NCT05664269Not ApplicableUnknown

Anabolic Properties of Canola

Role: collaborator

NCT01263912Not ApplicableCompleted

Essential Fatty Acid Nutrition For 1-2 Yr-Olds

Role: collaborator

NCT00744094Phase 1Completed

Resistance Training in Elderly

Role: collaborator

NCT02060864Not ApplicableCompleted

Effect of AN-PEP Enzyme on Gluten Digestion in Gluten Sensitive Individuals

Role: lead

NCT02192892Not ApplicableCompleted

Acceptability Among Children and Caregivers of Amylase Porridges

Role: lead

NCT01335503Not ApplicableCompleted

Effect of AN-PEP Enzyme on Gluten Digestion

Role: lead

NCT00810654Phase 1Completed

Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease

Role: collaborator

All 9 trials loaded